Back
Take-Two Interactive Software Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
50
TTWO
Take-Two Interactive Software
Last Price:
180.55
Seasonality Move:
6.26%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Sell
50
Take-Two Interactive Software (TTWO)
is a Sell
Is Take-Two Interactive Software a Buy, Sell or Hold?
- The current Take-Two Interactive Software [TTWO] share price is $179.39. The Score for TTWO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- TTWO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
TTWO Stock Price Chart
What is Take-Two Interactive Software's stock price today?
-
The Take-Two Interactive Software share price today is $179.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TTWO is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
TTWO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.47 | Buy |
| Relative Strength Index (14 RSI): | 81.34 | Buy |
| Chaikin Money Flow: | 133314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (153.69 - 168.85) | Buy |
| Bollinger Bands (100): | (147.34 - 161.56) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 75.47 | Buy |
| Chaikin Money Flow: | -747845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.34 - 58.08) | Buy |
| Bollinger Bands (100): | (43.86 - 53.38) | Buy |
TTWO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.45 | Buy |
| 20-day SMA: | 163.21 | Buy |
| 50-day SMA: | 157.25 | Buy |
| 200-day SMA: | 153.13 | Buy |
| 8-day EMA: | 171.53 | Buy |
| 20-day EMA: | 165.05 | Buy |
| 50-day EMA: | 159.28 | Buy |
| 200-day EMA: | 153.19 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.17 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 51.3 | Buy |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 60.15 | Buy |
| 20-day EMA: | 55.23 | Buy |
| 50-day EMA: | 51.77 | Buy |
| 200-day EMA: | 44.82 | Buy |
Take-Two Interactive Software Earnings Growth & TTWO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.29 per share, and an increase next year of $0.25 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Take-Two Interactive Software Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||